Laura Rodriguez Gallego
Director/Board Member at Onechain Immunotherapeutics
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Pablo Menéndez | M | - |
Onechain Immunotherapeutics
 Onechain Immunotherapeutics Medical SpecialtiesHealth Technology Onechain Immunotherapeutics develops oncological therapeutic tools. The company is based in Barcelona, Spain. The Spanish company was founded in 2020 by Pablo Menéndez. The CEO is Jorge Alemany. | - |
| Albert Ferrer Olivera | M | - |
Invivo Capital Partners SGEIC SA
 Invivo Capital Partners SGEIC SA Investment ManagersFinance Invivo Capital Partners SGEIC SA (Invivo Capital Partners) is a venture capital firm founded in 2019 by Albert Ferrer and Luis Pareras. The firm is headquartered in Barcelona, Spain. | 5 years |
| Luis Pareras | M | - |
Invivo Capital Partners SGEIC SA
Invivo Capital Partners SGEIC SA Investment ManagersFinance Invivo Capital Partners SGEIC SA (Invivo Capital Partners) is a venture capital firm founded in 2019 by Albert Ferrer and Luis Pareras. The firm is headquartered in Barcelona, Spain. | 5 years |
| Gemma Guinart | F | - |
Invivo Capital Partners SGEIC SA
Invivo Capital Partners SGEIC SA Investment ManagersFinance Invivo Capital Partners SGEIC SA (Invivo Capital Partners) is a venture capital firm founded in 2019 by Albert Ferrer and Luis Pareras. The firm is headquartered in Barcelona, Spain. | 4 years |
| Alberto Carrasco | M | - |
Invivo Capital Partners SGEIC SA
Invivo Capital Partners SGEIC SA Investment ManagersFinance Invivo Capital Partners SGEIC SA (Invivo Capital Partners) is a venture capital firm founded in 2019 by Albert Ferrer and Luis Pareras. The firm is headquartered in Barcelona, Spain. | 5 years |
| Stefanos Theoharis | M | 47 |
Onechain Immunotherapeutics
Onechain Immunotherapeutics Medical SpecialtiesHealth Technology Onechain Immunotherapeutics develops oncological therapeutic tools. The company is based in Barcelona, Spain. The Spanish company was founded in 2020 by Pablo Menéndez. The CEO is Jorge Alemany. | - |
| Ramón Gomis I de Barbarà | M | - |
University of Barcelona
| 13 years |
| Oscar Ferrer | M | - |
Invivo Capital Partners SGEIC SA
Invivo Capital Partners SGEIC SA Investment ManagersFinance Invivo Capital Partners SGEIC SA (Invivo Capital Partners) is a venture capital firm founded in 2019 by Albert Ferrer and Luis Pareras. The firm is headquartered in Barcelona, Spain. | 5 years |
| Albert Carreras | M | - |
Onechain Immunotherapeutics
Onechain Immunotherapeutics Medical SpecialtiesHealth Technology Onechain Immunotherapeutics develops oncological therapeutic tools. The company is based in Barcelona, Spain. The Spanish company was founded in 2020 by Pablo Menéndez. The CEO is Jorge Alemany. | - |
| Albert Ferrer | M | - |
Onechain Immunotherapeutics
Onechain Immunotherapeutics Medical SpecialtiesHealth Technology Onechain Immunotherapeutics develops oncological therapeutic tools. The company is based in Barcelona, Spain. The Spanish company was founded in 2020 by Pablo Menéndez. The CEO is Jorge Alemany. | - |
| Alberto Ferrer Oliveras | M | - |
Telomere Therapeutics SL
 Telomere Therapeutics SL Pharmaceuticals: MajorHealth Technology Telomere Technologies provides telomere technology services. The company is headquartered in Spain. | 4 years |
| Luis Garcia Pareras | M | - |
Telomere Therapeutics SL
Telomere Therapeutics SL Pharmaceuticals: MajorHealth Technology Telomere Technologies provides telomere technology services. The company is headquartered in Spain. | 4 years |
| Laura Rodriguez | F | - |
Onechain Immunotherapeutics
Onechain Immunotherapeutics Medical SpecialtiesHealth Technology Onechain Immunotherapeutics develops oncological therapeutic tools. The company is based in Barcelona, Spain. The Spanish company was founded in 2020 by Pablo Menéndez. The CEO is Jorge Alemany. | - |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Jorge Alemany | M | - |
Onechain Immunotherapeutics
Onechain Immunotherapeutics Medical SpecialtiesHealth Technology Onechain Immunotherapeutics develops oncological therapeutic tools. The company is based in Barcelona, Spain. The Spanish company was founded in 2020 by Pablo Menéndez. The CEO is Jorge Alemany. | - |
| Dmitry Matveev | M | - |
Universitat Autònoma de Barcelona
| 6 years |
| Lander Egaña-Gorroño | M | - |
University of Barcelona
| 5 years |
| Daniela Hauser | M | - |
Universitat Autònoma de Barcelona
| 6 years |
| Antonio Herce | M | - |
University of Barcelona
| 1 years |
| Virginia Gomez Onate | F | - |
University of Barcelona
| 1 years |
| Jordi Ferran Penina | M | - |
University of Barcelona
| 5 years |
| Eric Carreras Codo | M | - |
University of Barcelona
| 5 years |
| Mar Fernandez Sanchez | F | - |
University of Barcelona
| 2 years |
| Artur Bardera Echeverria | M | - |
University of Barcelona
| 4 years |
| Marc Castilblanco Genebat | M | - |
University of Barcelona
| 4 years |
| Miguel Moleres | M | - |
University of Barcelona
| 5 years |
| Maria Joana Dantas Vaz Pais | M | - |
Universitat Autònoma de Barcelona
| 3 years |
| Pol Fañanás Soriano | M | - |
University of Barcelona
| 5 years |
| Bruno Lusic | M | - |
Universitat Autònoma de Barcelona
| 5 years |
| Daniel Giralt | M | - |
Universitat Autònoma de Barcelona
| 4 years |
| Javier Gonzalez Manzano | M | - |
University of Barcelona
| 1 years |
| Genis Puig Oliveras | M | - |
University of Barcelona
| 1 years |
| Víctor Murillo Huamán | M | 61 |
University of Barcelona
| 1 years |
| Alejo Ortuño Balius | M | - |
University of Barcelona
| 4 years |
| Marc Camprubi Artal | M | - |
University of Barcelona
| 6 years |
| Sergi Mas Rodriguez | M | - |
Universitat Autònoma de Barcelona
| 1 years |
| Jan-Nicolas Garbe | M | 43 |
Universitat Autònoma de Barcelona
| 2 years |
| Walter Plischuk | M | 51 |
University of Barcelona
| 2 years |
| Oscar Ochoa Humara | M | - |
Universitat Autònoma de Barcelona
| 1 years |
| Sonia Jerez Burdeus | F | 54 |
University of Barcelona
| 25 years |
| Inmaculada Brescó Cascalló | F | - |
University of Barcelona
| 4 years |
| Agata Czerniakowska | F | 41 |
University of Barcelona
| 1 years |
| Elisabet Oter | F | - |
University of Barcelona
| 4 years |
| Sebastian Rossello | M | 74 |
University of Barcelona
| 3 years |
| Rubén González Amoedo | M | - |
University of Barcelona
| 4 years |
| Borja Casanovas Domenech | M | - |
University of Barcelona
| 4 years |
| Guillem Laporta | M | - |
Universitat Autònoma de Barcelona
| 4 years |
| Andrea Chordi Garriga | F | - |
University of Barcelona
| 1 years |
| Antoni Rosselló Rofes | M | - |
University of Barcelona
| 1 years |
| Laura Bosch Ferreté | F | - |
University of Barcelona
| 4 years |
| Rodrigo Gaze | M | - |
University of Barcelona
| 1 years |
| Ferran Bernaldo | M | - |
University of Barcelona
| 2 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| Spain | 51 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Laura Rodriguez Gallego
- Personal Network
